Postby WifeOfMike » Fri Oct 31, 2014 8:33 pm
'Breakthrough' for Merck's Keytruda as firm posts Q3 declinehttp://www.pharmatimes.com/Article/14-1 ... cline.aspxVicki
Bad Ass WIFE
Hubs: CRC IVA,T3, N0, M1A
Resect/LN Mets 10/12
Folfox4/Avastin 11/12-5/13
Folfiri/Erbitux 6/13-10/13
Stivarga 12/13-4/14
Trial 4/14-/14
Trial 8/14-11/14
HOME Hospice 11/17/14
Guardian Angel 1/1/15
Cost of HOPE? PRICELESS